Search results
Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 19 hours agoBy leveraging its strengths and addressing its weaknesses, AbbVie can capitalize on opportunities and mitigate threats, positioning itself for continued...
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
Zacks via Yahoo Finance· 3 days agoAbbVie (ABBV) has recently been on Zacks.com's list of the most searched stocks. Therefore, you...
Better Dividend Stock: AbbVie or Johnson & Johnson?
Motley Fool via Yahoo Finance· 7 days agoAbbVie At first glance, AbbVie doesn't seem like a particularly attractive stock right now. The company's revenue is dropping. Last year ...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ...Claims - Comfort Systems USA (NYSE:FIX), ...
Benzinga· 1 day agoThe first-quarter 2024 earnings season is almost over as far as large drugmakers are concerned. Eli...
Investors Take AbbVie To The Woodshed. But Its Woes Are 'Unfounded.'Investors Take AbbVie To The...
Investor's Business Daily· 5 days agoOn Friday, AbbVie beat first-quarter expectations, largely on the back of its immunology franchise....
AbbVie (NYSE:ABBV) Price Target Cut to $187.00
ETF DAILY NEWS· 4 days agoBarclays‘s target price would suggest a potential upside of 14.94% from the company’s previous close. Several other equities research analysts have also recently commented on ABBV. BMO Capital ...
AbbVie (NYSE:ABBV) Price Target Cut to $180.00 by Analysts at BMO Capital Markets
ETF DAILY NEWS· 5 days agoA number of other analysts have also recently weighed in on the company. Truist Financial raised their price objective on AbbVie from $180.00 to $195.00 and gave the
Barclays lowers AbbVie shares target on Humira sales erosion concerns By Investing.com
Investing.com· 6 days ago:ABBV) shares, reducing the price target to $187 from the previous $195. The revision was attributed...
AbbVie (ABBV) Could Be a Great Choice
Zacks via Yahoo Finance· 4 days agoDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes?...
AbbVie (NYSE:ABBV) Shares Down 0.5% After Analyst Downgrade
ETF DAILY NEWS· 4 days agoAbbVie Inc. (NYSE:ABBV – Get Free Report) shares fell 0.5% on Monday after Barclays lowered their price target on the stock from $195.00 to $187.00. < ...